Coordination Pharmaceuticals, Inc. (CPI), is a privately held immuno-oncology company founded to develop anticancer products that can address unmet medical needs and improve patient care. Our proprietary nanoscale coordination polymer (NCP) platform combines synergistic therapeutics to specifically target solid tumors, increasing efficacy while simultaneously reducing toxicity.
The NCP platform was pioneered by the lab of Pr...
Coordination Pharmaceuticals, Inc. (CPI), is a privately held immuno-oncology company founded to develop anticancer products that can address unmet medical needs and improve patient care. Our proprietary nanoscale coordination polymer (NCP) platform combines synergistic therapeutics to specifically target solid tumors, increasing efficacy while simultaneously reducing toxicity.
The NCP platform was pioneered by the lab of Professor Wenbin Lin at the University of Chicago. As a versatile technology platform, NCP components can be purposefully chosen to synergize with and enhance currently existing therapies.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.